Author

Nyasige Chibunu

OpenAlex ID: A5115793745

Safety, bactericidal activity, and pharmacokinetics of the antituberculosis drug candidate BTZ-043 in South Africa (PanACEA-BTZ-043–02): an open-label, dose-expansion, randomised, controlled, phase 1b/2a trial

2025 · Norbert Heinrich, Veronique de Jager, et al. · The Lancet Microbe · 30

Works count: 1

Citation count: 30

H-index: 1

I10-index: 1